Scandinavian ChemoTech AB Company Description

Scandinavian ChemoTech AB (publ) offers cancer care and pain management solutions in Sweden.

The company offers IQWave, an electroporation device, used for electrochemotherapy and treatment of head and neck cancer, squamous cell carcinoma, malignant melanoma, basal cell carcinoma, adenocarcinoma of the breast and salivary gland, hypernephroma, kaposi sarcoma, and transitional cell carcinoma.

It also offers Vetiqure for the treatment of superficial tumors in dogs, cats, and horses. The company markets its products through distribution channels and a network of human medicine opinion leaders in the Middle East, Asia, India, and Africa.

Scandinavian ChemoTech AB (publ) was incorporated in 2013 and is headquartered in Lund, Sweden.

Scandinavian ChemoTech AB (publ)

Country	Sweden
Founded	2013
Industry	Biotechnology
Sector	Healthcare
Employees	6
CEO	Stefan Frick

Contact Details

Address: Medicon Village Lund, 223 63 Sweden
Phone	46 1 02 18 93 00
Website	chemotech.se

Stock Details

Ticker Symbol	CMOTEC.B
Exchange	Nasdaq Stockholm
Fiscal Year	January - December
Reporting Currency	SEK
ISIN Number	SE0009242654
SIC Code	3845

Key Executives

Name	Position
Stefan Mohan Frick	Founder, Chief Executive Officer, President and Director
Ann Ohlsson	Head of Finance